Deregulated MIR335 that targets MAPK1 is implicated in poor outcome of paediatric acute lymphoblastic leukaemia

British Journal of Haematology

Volumn 163, Issue 1, 2013, Pages 93-103

  Yan, Junli ^a   Jiang, Nan ^b   Huang, Gaofeng ^a   Tay, Jim L S ^c   Lin, Baohong ^d   Bi, Chonglei ^a   Koh, Grace S ^b   Li, Zhenhua ^b   Tan, Joy ^c   Chung, Tae Hoon ^a   Lu, Yi ^b   Ariffin, Hany ^e   Kham, Shirley K Y ^b   Yeoh, Allen E J ^b,d   Chng, Wee Joo ^a,c,d  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c Dept Medicine Endocrinol Diabet   (Singapore)

^d NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

^e UNIVERSITY MALAYA MEDICAL CENTRE   (Malaysia)

Author keywords

Clinical outcome; MAPK1; MIR335; Paediatric acute lymphoblastic leukaemia; Prednisolone

Indexed keywords

MICRORNA; MICRORNA 335; MITOGEN ACTIVATED PROTEIN KINASE 1; PREDNISOLONE; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; APOPTOSIS; ARTICLE; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER REGRESSION; CANCER RESISTANCE; CONTROLLED STUDY; DOWN REGULATION; DRUG SENSITIZATION; ENZYME ACTIVITY; ENZYME REGULATION; FEMALE; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE IDENTIFICATION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN TARGETING; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; RNA SEQUENCE;

CLINICAL OUTCOME; MAPK1; MIR335; PAEDIATRIC ACUTE LYMPHOBLASTIC LEUKAEMIA; PREDNISOLONE;

CELL LINE, TUMOR; CHILD; CHILD, PRESCHOOL; COMPUTATIONAL BIOLOGY; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, LEUKEMIC; GENETIC VECTORS; HUMANS; LENTIVIRUS; MALE; MAP KINASE SIGNALING SYSTEM; MICRORNAS; MITOGEN-ACTIVATED PROTEIN KINASE 1; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PREDNISOLONE; PROGNOSIS; RECURRENCE;

EID: 84883761376     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12489     Document Type: Article

References (32)

1. Agirre, X., Martinez-Climent, J.A., Odero, M.D. & Prosper, F. (2012) Epigenetic regulation of miRNA genes in acute leukemia. Leukemia, 26, 395-403.
2. Bartel, D.P. (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell, 116, 281-297.
3. van Dongen, J.J., Seriu, T., Panzer-Grumayer, E.R., Biondi, A., Pongers-Willemse, M.J., Corral, L., Stolz, F., Schrappe, M., Masera, G., Kamps, W.A., Gadner, H., van Wering, E.R., Ludwig, W.D., Basso, G., de Bruijn, M.A., Cazzaniga, G., Hettinger, K., van der Does-van den Berg, A., Hop, W.C., Riehm, H. & Bartram, C.R. (1998) Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood. The Lancet, 352, 1731-1738.
4. Dordelmann, M., Reiter, A., Borkhardt, A., Ludwig, W.D., Gotz, N., Viehmann, S., Gadner, H., Riehm, H. & Schrappe, M. (1999) Prednisone response is the strongest predictor of treatment outcome in infant acute lymphoblastic leukemia. Blood, 94, 1209-1217.
5. Guo, H., Ingolia, N.T., Weissman, J.S. & Bartel, D.P. (2010) Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature, 466, 835-840.
6. Han, B.W., Feng, D.D., Li, Z.G., Luo, X.Q., Zhang, H., Li, X.J., Zhang, X.J., Zheng, L.L., Zeng, C.W., Lin, K.Y., Zhang, P., Xu, L. & Chen, Y.Q. (2011) A set of miRNAs that involve in the pathways of drug resistance and leukemic stem-cell differentiation is associated with the risk of relapse and glucocorticoid response in childhood ALL. Human Molecular Genetics, 20, 4903-4915.
7. Hogan, L.E., Meyer, J.A., Yang, J., Wang, J., Wong, N., Yang, W., Condos, G., Hunger, S.P., Raetz, E., Saffery, R., Relling, M.V., Bhojwani, D., Morrison, D.J. & Carroll, W.L. (2011) Integrated genomic analysis of relapsed childhood acute lymphoblastic leukemia reveals therapeutic strategies. Blood, 118, 5218-5226.
8. Jiang, N., Koh, G.S., Lim, J.Y., Kham, S.K., Ariffin, H., Chew, F.T. & Yeoh, A.E. (2011) BIM is a prognostic biomarker for early prednisolone response in pediatric acute lymphoblastic leukemia. Experimental Hematology 39, 321-329, 329.e1-329.e3
9. Kotani, A., Ha, D., Hsieh, J., Rao, P.K., Schotte, D., den Boer, M.L., Armstrong, S.A. & Lodish, H.F. (2009) miR-128b is a potent glucocorticoid sensitizer in MLL-AF4 acute lymphocytic leukemia cells and exerts cooperative effects with miR-221. Blood, 114, 4169-4178.
10. Linger, R.M., DeRyckere, D., Brandao, L., Sawczyn, K.K., Jacobsen, K.M., Liang, X., Keating, A.K. & Graham, D.K. (2009) Mer receptor tyrosine kinase is a novel therapeutic target in pediatric B-cell acute lymphoblastic leukemia. Blood, 114, 2678-2687.
11. Lujambio, A. & Lowe, S.W. (2012) The microcosmos of cancer. Nature, 482, 347-355.
12. McCubrey, J.A., Steelman, L.S., Chappell, W.H., Abrams, S.L., Wong, E.W., Chang, F., Lehmann, B., Terrian, D.M., Milella, M., Tafuri, A., Stivala, F., Libra, M., Basecke, J., Evangelisti, C., Martelli, A.M. & Franklin, R.A. (2007) Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance. Biochimica et Biophysica Acta, 1773, 1263-1284.
13. Nair, V.S., Maeda, L.S. & Ioannidis, J.P. (2012) Clinical outcome prediction by microRNAs in human cancer: a systematic review. Journal of the National Cancer Institute, 104, 528-540.
14. de Oliveira, J.C., Brassesco, M.S., Scrideli, C.A., Tone, L.G. & Narendran, A. (2012) MicroRNA expression and activity in pediatric acute lymphoblastic leukemia (ALL). Pediatric Blood Cancer, 59, 599-604.
15. Png, K.J., Yoshida, M., Zhang, X.H., Shu, W., Lee, H., Rimner, A., Chan, T.A., Comen, E., Andrade, V.P., Kim, S.W., King, T.A., Hudis, C.A., Norton, L., Hicks, J., Massague, J. & Tavazoie, S.F. (2011) MicroRNA-335 inhibits tumor reinitiation and is silenced through genetic and epigenetic mechanisms in human breast cancer. Genes & Development, 25, 226-231.
16. Pui, C.H., Relling, M.V. & Downing, J.R. (2004) Acute lymphoblastic leukemia. New England Journal of Medicine, 350, 1535-1548.
17. Rambal, A.A., Panaguiton, Z.L., Kramer, L., Grant, S. & Harada, H. (2009) MEK inhibitors potentiate dexamethasone lethality in acute lymphoblastic leukemia cells through the pro-apoptotic molecule BIM. Leukemia, 23, 1744-1754.
18. Rigoutsos, I. (2009) New tricks for animal microRNAS: targeting of amino acid coding regions at conserved and nonconserved sites. Cancer Research, 69, 3245-3248.
19. Roman-Gomez, J., Agirre, X., Jimenez-Velasco, A., Arqueros, V., Vilas-Zornoza, A., Rodriguez-Otero, P., Martin-Subero, I., Garate, L., Cordeu, L., San Jose-Eneriz, E., Martin, V., Castillejo, J.A., Bandres, E., Calasanz, M.J., Siebert, R., Heiniger, A., Torres, A. & Prosper, F. (2009) Epigenetic regulation of microRNAs in acute lymphoblastic leukemia. Journal of Clinical Oncology, 27, 1316-1322.
20. Scarola, M., Schoeftner, S., Schneider, C. & Benetti, R. (2010) miR-335 directly targets Rb1 (pRb/p105) in a proximal connection to p53-dependent stress response. Cancer Research, 70, 6925-6933.
21. Schotte, D., De Menezes, R.X., Akbari Moqadam, F., Khankahdani, L.M., Lange-Turenhout, E., Chen, C., Pieters, R. & Den Boer, M.L. (2011) MicroRNA characterize genetic diversity and drug resistance in pediatric acute lymphoblastic leukemia. Haematologica, 96, 703-711.
22. Schrappe, M., Arico, M., Harbott, J., Biondi, A., Zimmermann, M., Conter, V., Reiter, A., Valsecchi, M.G., Gadner, H., Basso, G., Bartram, C.R., Lampert, F., Riehm, H. & Masera, G. (1998) Philadelphia chromosome-positive (Ph+) childhood acute lymphoblastic leukemia: good initial steroid response allows early prediction of a favorable treatment outcome. Blood, 92, 2730-2741.
23. Sionov, R.V., Spokoini, R., Kfir-Erenfeld, S., Cohen, O. & Yefenof, E. (2008) Mechanisms regulating the susceptibility of hematopoietic malignancies to glucocorticoid-induced apoptosis. Advances in Cancer Research, 101, 127-248.
24. Stumpel, D.J., Schotte, D., Lange-Turenhout, E.A., Schneider, P., Seslija, L., de Menezes, R.X., Marquez, V.E., Pieters, R., den Boer, M.L. & Stam, R.W. (2011) Hypermethylation of specific microRNA genes in MLL-rearranged infant acute lymphoblastic leukemia: major matters at a micro scale. Leukemia, 25, 429-439.
25. Tanaka, T., Okabe, T., Gondo, S., Fukuda, M., Yamamoto, M., Umemura, T., Tani, K., Nomura, M., Goto, K., Yanase, T. & Nawata, H. (2006) Modification of glucocorticoid sensitivity by MAP kinase signaling pathways in glucocorticoid-induced T-cell apoptosis. Experimental Hematology, 34, 1542-1552.
26. Tavazoie, S.F., Alarcon, C., Oskarsson, T., Padua, D., Wang, Q., Bos, P.D., Gerald, W.L. & Massague, J. (2008) Endogenous human microRNAs that suppress breast cancer metastasis. Nature, 451, 147-152.
27. Xu, Y., Zhao, F., Wang, Z., Song, Y., Luo, Y., Zhang, X., Jiang, L., Sun, Z., Miao, Z. & Xu, H. (2012) MicroRNA-335 acts as a metastasis suppressor in gastric cancer by targeting Bcl-w and specificity protein 1. Oncogene, 31, 1398-1407.
28. Yan, Z., Xiong, Y., Xu, W., Gao, J., Cheng, Y., Wang, Z., Chen, F. & Zheng, G. (2012) Identification of hsa-miR-335 as a prognostic signature in gastric cancer. PLoS ONE, 7, e40037.
29. Yeoh, E.J., Ross, M.E., Shurtleff, S.A., Williams, W.K., Patel, D., Mahfouz, R., Behm, F.G., Raimondi, S.C., Relling, M.V., Patel, A., Cheng, C., Campana, D., Wilkins, D., Zhou, X., Li, J., Liu, H., Pui, C.H., Evans, W.E., Naeve, C., Wong, L. & Downing, J.R. (2002) Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell, 1, 133-143.
30. Yeoh, A.E., Ariffin, H., Chai, E.L., Kwok, C.S., Chan, Y.H., Ponnudurai, K., Campana, D., Tan, P.L., Chan, M.Y., Kham, S.K., Chong, L.A., Tan, A.M., Lin, H.P. & Quah, T.C. (2012) Minimal residual disease-guided treatment deintensification for children with acute lymphoblastic leukemia: results from the Malaysia-Singapore acute lymphoblastic leukemia 2003 study. Journal of Clinical Oncology 30, 2384-2392
31. Yu, S.L., Chen, H.Y., Chang, G.C., Chen, C.Y., Chen, H.W., Singh, S., Cheng, C.L., Yu, C.J., Lee, Y.C., Chen, H.S., Su, T.J., Chiang, C.C., Li, H.N., Hong, Q.S., Su, H.Y., Chen, C.C., Chen, W.J., Liu, C.C., Chan, W.K., Li, K.C., Chen, J.J. & Yang, P.C. (2008) MicroRNA signature predicts survival and relapse in lung cancer. Cancer Cell, 13, 48-57.
32. Zhang, H., Luo, X.Q., Zhang, P., Huang, L.B., Zheng, Y.S., Wu, J., Zhou, H., Qu, L.H., Xu, L. & Chen, Y.Q. (2009) MicroRNA patterns associated with clinical prognostic parameters and CNS relapse prediction in pediatric acute leukemia. PLoS ONE, 4, e7826.